Otolaryngology · Melville, NY
NPI
1447460134
Since 2007
Specialty
Otolaryngology
Code 207Y00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
115 Broadhollow Rd
Melville, NY, 11747
Phone (631) 591-9990
Groups this clinician bills Medicare through
Medicare paid, 2024
$414K
2,783 services
Medicare patients, 2024
645
Average age 75
Drug cost, 2024
$34K
1,318 prescriptions
Company payments, 2025
$3,320
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Danny Meslemani was code 99213 (office e&m - established), 847 times for 455 patients. In total Danny Meslemani billed 2,783 services in 40 codes, and Medicare paid $414K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 847 | 455 | $85.16 | $72K |
| 31231 Nasal/Sinus Endoscopy | Office | 565 | 409 | $173.34 | $98K |
| 69210 Other Organ Systems | Office | 543 | 385 | $30.91 | $17K |
| 99203 Office E&M - New | Office | 147 | 147 | $100.82 | $15K |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 97 | 97 | $34.85 | $3,381 |
| 92511 Treatment - Miscellaneous | Office | 91 | 87 | $113.16 | $10K |
| 31575 Other Organ Systems | Office | 85 | 76 | $121.74 | $10K |
| 99204 Office E&M - New | Office | 66 | 66 | $156.39 | $10K |
| 99214 Office E&M - Established | Office | 59 | 56 | $122.57 | $7,232 |
| 31237 Nasal/Sinus Endoscopy | Office | 55 | 29 | $375.07 | $21K |
| 30117 Other Organ Systems | Office | 42 | 26 | $499.17 | $21K |
| 30903 Other Organ Systems | Office | 33 | 23 | $202.57 | $6,685 |
| 31242 Nasal/Sinus Endoscopy | Office | 30 | 30 | $2,516.01 | $75K |
| 95992 Treatment - Miscellaneous | Office | 25 | 12 | $38.66 | $966 |
| 69200 Other Organ Systems | Office | 16 | 15 | $57.00 | $912 |
By year: 2022 $270K for 2,647 services; 2023 $365K for 2,719 services; 2024 $414K for 2,783 services.
Medicare prescription drug claims, 2024
In 2024, the drug Danny Meslemani prescribed most often to Medicare patients was Ipratropium Bromide, with 223 prescriptions and refills. In total Danny Meslemani wrote 1,318 Medicare prescriptions that cost $34K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 223 | 236 | 112 | $4,967 |
| Fluticasone Propionate Generic | 174 | 198 | 81 | $1,649 |
| Azelastine Hcl Generic | 151 | 171 | 68 | $3,894 |
| Mometasone Furoate Generic | 116 | 130 | 72 | $6,277 |
| Olopatadine Hcl Generic | 99 | 114 | 68 | $8,178 |
| Mupirocin Generic | 64 | 64 | 58 | $396 |
| Montelukast Sodium Generic | 58 | 78 | 12 | $542 |
| Cefuroxime Cefuroxime Axetil | 45 | 45 | 38 | $954 |
| Levocetirizine Dihydrochloride Generic | 45 | 53 | 15 | $279 |
| Prednisone Generic | 37 | 37 | 32 | $174 |
| Doxycycline Monohydrate Generic | 35 | 35 | 32 | $383 |
| Pantoprazole Sodium Generic | 23 | 39 | Under 11 | $288 |
| Famotidine Generic | 23 | 37 | Under 11 | $58 |
| Meclizine Hcl Generic | 19 | 19 | 13 | $92.8 |
| Chlorhexidine Gluconate Generic | 17 | 17 | 13 | $96.11 |
Brand drugs: 14 claims; generic drugs: 1,304 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Danny Meslemani $3,320 ($3,320 in general payments such as food, travel and fees) from 15 companies. The largest payer was Neurent Medical Limited with $1,670.
| Company | Payments | Amount |
|---|---|---|
| Neurent Medical Limited | 14 | $1,670 |
| Aerin Medical Inc. | 7 | $657 |
| Spirair, Inc. | 1 | $248 |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $192 |
| GlaxoSmithKline, LLC. GSK | 7 | $171 |
| Medtronic, Inc. MDT | 1 | $68.27 |
| Optinose US, Inc. | 3 | $66.28 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 2 | $43.36 |
| ALK-Abello, Inc | 2 | $42.43 |
| Hikma Pharmaceuticals USA HIK.L | 2 | $39.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.